Loading view.
Featured
Featured Industry Symposium
IS01: Join us to hear thought leaders discuss a newly approved combination therapy that includes RYBREVANT® (amivantamab-vmjw)
Room 20BC, San Diego Convention Center
Presented by Johnson & Johnson
Featured Satellite CME Symposium
IS06: Do We Have Sea Change in Small Cell Lung Cancer? What Recent Clinical Trial Data Tell Us About Treatment Decision-Making in Real World Settings, What’s Next for Emerging Novel Strategies
Room 20BC, San Diego Convention Center
Presented by Physicians’ Education Resource
Supported by an educational grant from AstraZeneca.
Featured Satellite CME Symposium
IS12: What’s Next for HER2- and Trop2-Directed ADCs in Lung Cancer: How Emerging Trial Data Will Impact Our Clinics Today and Tomorrow…
Room 20D, San Diego Convention Center
Presented by Physicians’ Education Resource
Supported by an educational grant from AstraZeneca.
Featured Industry Symposium
IS13: Accelerating Treatment Initiation with Next-Day NGS: Insights from a Multidisciplinary Collaboration Program in Precision Oncology
Room 33ABC, San Diego Convention Center
Presented by Thermo Fisher Scientific
Featured Satellite CME Symposium
IS17: Lung Cancer Tumor Board®: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
Room 30DE, San Diego Convention Center
Presented by Physicians’ Education Resource
Supported by an educational grant from Novartis Pharmaceuticals Corporation, Rigel Pharmaceuticals, Inc.
Featured Satellite CME Symposium
The Implications of Recent Data Sets for the Current and Future Management of Lung Cancer
Live Webcast Series
Presented by Research To Practice